World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
241 PhotoCure ASA $148.3 M

(July 1, 2024)

Norway Norway Healthcare Norway Drug Manufacturers—Specialty & Generic
242 Pharma Foods International Co. Ltd $144.6 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
243 HAEMATO AG $144.4 M

(Jan. 1, 2024)

Germany German Healthcare German Drug Manufacturers—Specialty & Generic
244 Theratechnologies Inc. $140.9 M

(July 1, 2025)

Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
245 Shield Therapeutics plc $140.8 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
246 REYON Pharmaceutical Co. Ltd $140.6 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
247 Olainfarm AS $138.5 M

(Dec. 1, 2021)

Latvia Latvia Healthcare Latvia Drug Manufacturers—Specialty & Generic
248 JW Lifescience Corp $137.5 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
249 Planet 13 Holdings, Inc. $133.9 M

(July 1, 2023)

United States US Healthcare US Drug Manufacturers—Specialty & Generic
250 Ignite International Brands Ltd $132.2 M

(Aug. 1, 2022)

Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
251 Hana Pharm Co. Ltd $132.2 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
252 DV Biomed Co. Ltd $124.4 M

(Nov. 1, 2021)

Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
253 Orient EuroPharma Co. Ltd $123.5 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
254 Cannara Biotech, Inc. $123.4 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
255 Fuso Pharmaceutical Industries,Ltd. $121.1 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
256 Incannex Healthcare Limited $116.3 M

(July 1, 2023)

Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
257 AB Science SA $113.5 M France French Healthcare French Drug Manufacturers—Specialty & Generic
258 Venture Life Group plc $112.0 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
259 HLS Therapeutics Inc. $111.1 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
260 PT Darya-Varia Laboratoria Tbk $111.0 M Indonesia Indonesian Healthcare Indonesian Drug Manufacturers—Specialty & Generic
261 Laboratorios Richmond S.A.C.I.F. $111.0 M Argentina Argentinian Healthcare Argentinian Drug Manufacturers—Specialty & Generic
262 Lincoln Pharmaceuticals Ltd $110.7 M India Indian Healthcare Indian Drug Manufacturers—Specialty & Generic
263 Biosyent, Inc. $104.9 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
264 Nutritional High International, Inc. $102.2 M

(Nov. 1, 2021)

Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
265 Cardiol Therapeutics Inc. $100.7 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
266 Sakar Healthcare Ltd $99.2 M India Indian Healthcare Indian Drug Manufacturers—Specialty & Generic
267 Recro Pharma, Inc. $97.4 M

(June 1, 2022)

United States US Healthcare US Drug Manufacturers—Specialty & Generic
268 Shineco, Inc. $97.2 M

(June 1, 2022)

China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
269 Dali Pharmaceutical Co. Ltd $96.9 M

(Jan. 1, 2025)

China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
270 Taiko Pharmaceutical Co.,Ltd. $96.7 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

241. PhotoCure ASA

Company Profile: PhotoCure ASA
Market Cap (USD): $148.3 M (July 1, 2024)
Country: Norway
Sector: Norway Healthcare
Industry: Norway Drug Manufacturers—Specialty & Generic

242. Pharma Foods International Co. Ltd

Company Profile: Pharma Foods International Co. Ltd
Market Cap (USD): $144.6 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

243. HAEMATO AG

Company Profile: HAEMATO AG
Market Cap (USD): $144.4 M (Jan. 1, 2024)
Country: Germany
Sector: German Healthcare
Industry: German Drug Manufacturers—Specialty & Generic

244. Theratechnologies Inc.

Company Profile: Theratechnologies Inc.
Market Cap (USD): $140.9 M (July 1, 2025)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

245. Shield Therapeutics plc

Company Profile: Shield Therapeutics plc
Market Cap (USD): $140.8 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

246. REYON Pharmaceutical Co. Ltd

Company Profile: REYON Pharmaceutical Co. Ltd
Market Cap (USD): $140.6 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

247. Olainfarm AS

Company Profile: Olainfarm AS
Market Cap (USD): $138.5 M (Dec. 1, 2021)
Country: Latvia
Sector: Latvia Healthcare
Industry: Latvia Drug Manufacturers—Specialty & Generic

248. JW Lifescience Corp

Company Profile: JW Lifescience Corp
Market Cap (USD): $137.5 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

249. Planet 13 Holdings, Inc.

Company Profile: Planet 13 Holdings, Inc.
Market Cap (USD): $133.9 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

250. Ignite International Brands Ltd

Company Profile: Ignite International Brands Ltd
Market Cap (USD): $132.2 M (Aug. 1, 2022)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

251. Hana Pharm Co. Ltd

Company Profile: Hana Pharm Co. Ltd
Market Cap (USD): $132.2 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

252. DV Biomed Co. Ltd

Company Profile: DV Biomed Co. Ltd
Market Cap (USD): $124.4 M (Nov. 1, 2021)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

253. Orient EuroPharma Co. Ltd

Company Profile: Orient EuroPharma Co. Ltd
Market Cap (USD): $123.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

254. Cannara Biotech, Inc.

Company Profile: Cannara Biotech, Inc.
Market Cap (USD): $123.4 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

255. Fuso Pharmaceutical Industries,Ltd.

Company Profile: Fuso Pharmaceutical Industries,Ltd.
Market Cap (USD): $121.1 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

256. Incannex Healthcare Limited

Company Profile: Incannex Healthcare Limited
Market Cap (USD): $116.3 M (July 1, 2023)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

257. AB Science SA

Company Profile: AB Science SA
Market Cap (USD): $113.5 M
Country: France
Sector: French Healthcare
Industry: French Drug Manufacturers—Specialty & Generic

258. Venture Life Group plc

Company Profile: Venture Life Group plc
Market Cap (USD): $112.0 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

259. HLS Therapeutics Inc.

Company Profile: HLS Therapeutics Inc.
Market Cap (USD): $111.1 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

260. PT Darya-Varia Laboratoria Tbk

Company Profile: PT Darya-Varia Laboratoria Tbk
Market Cap (USD): $111.0 M
Country: Indonesia
Sector: Indonesian Healthcare
Industry: Indonesian Drug Manufacturers—Specialty & Generic

261. Laboratorios Richmond S.A.C.I.F.

Company Profile: Laboratorios Richmond S.A.C.I.F.
Market Cap (USD): $111.0 M
Country: Argentina
Sector: Argentinian Healthcare
Industry: Argentinian Drug Manufacturers—Specialty & Generic

262. Lincoln Pharmaceuticals Ltd

Company Profile: Lincoln Pharmaceuticals Ltd
Market Cap (USD): $110.7 M
Country: India
Sector: Indian Healthcare
Industry: Indian Drug Manufacturers—Specialty & Generic

263. Biosyent, Inc.

Company Profile: Biosyent, Inc.
Market Cap (USD): $104.9 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

264. Nutritional High International, Inc.

Company Profile: Nutritional High International, Inc.
Market Cap (USD): $102.2 M (Nov. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

265. Cardiol Therapeutics Inc.

Company Profile: Cardiol Therapeutics Inc.
Market Cap (USD): $100.7 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

266. Sakar Healthcare Ltd

Company Profile: Sakar Healthcare Ltd
Market Cap (USD): $99.2 M
Country: India
Sector: Indian Healthcare
Industry: Indian Drug Manufacturers—Specialty & Generic

267. Recro Pharma, Inc.

Company Profile: Recro Pharma, Inc.
Market Cap (USD): $97.4 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

268. Shineco, Inc.

Company Profile: Shineco, Inc.
Market Cap (USD): $97.2 M (June 1, 2022)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

269. Dali Pharmaceutical Co. Ltd

Company Profile: Dali Pharmaceutical Co. Ltd
Market Cap (USD): $96.9 M (Jan. 1, 2025)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

270. Taiko Pharmaceutical Co.,Ltd.

Company Profile: Taiko Pharmaceutical Co.,Ltd.
Market Cap (USD): $96.7 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

Stay in touch